HeraMED Limited (ASX:HMD)
0.0410
-0.0010 (-2.38%)
May 18, 2026, 3:39 PM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 47.35 million as of May 18, 2026. Its market cap has increased by 184.64% in one year.
Market Cap
47.35M
Enterprise Value
45.98M
Revenue
431.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 47.35M, an increase of 200.56%. That is a compound annual growth rate of 15.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 48.51M | 25.91% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 115.48M |
| Cleo Diagnostics | 94.43M |
| Epiminder | 93.03M |
| Compumedics | 55.93M |
| Nova Eye Medical | 35.61M |
| Micro-X | 33.54M |
| CleanSpace Holdings | 31.56M |
| CurveBeam AI | 27.71M |